Current use of fecal microbiota transfer in patients with hematologic diseases: a survey on behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

Bone Marrow Transplant. 2023 Dec;58(12):1419-1421. doi: 10.1038/s41409-023-02115-z. Epub 2023 Oct 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Fecal Microbiota Transplantation
  • Hematologic Diseases* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Surveys and Questionnaires